| Product dosage: 300mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.87 | $52.05 (0%) | 🛒 Add to cart |
| 90 | $0.79 | $78.08 $71.07 (9%) | 🛒 Add to cart |
| 120 | $0.74 | $104.10 $89.09 (14%) | 🛒 Add to cart |
| 180 | $0.70 | $156.15 $126.12 (19%) | 🛒 Add to cart |
| 270 | $0.67 | $234.23 $182.18 (22%) | 🛒 Add to cart |
| 360 | $0.66
Best per pill | $312.31 $238.23 (24%) | 🛒 Add to cart |
Synonyms
| |||
Similar products
More info:
allopurinol
Allopurinol is a xanthine oxidase inhibitor, a medication primarily used to manage chronic hyperuricemia and prevent gout flares and uric acid nephrolithiasis. It’s not a dietary supplement or medical device but a prescription drug that has been a cornerstone in rheumatology and nephrology for decades. The drug works by inhibiting the enzyme responsible for converting hypoxanthine to xanthine and then to uric acid, thereby reducing serum urate levels. Its significance lies in its ability to prevent the long-term complications of hyperuricemia, such as tophaceous gout and uric acid kidney stones, rather than providing immediate relief from acute symptoms.
Amoxil: Effective Bacterial Infection Treatment - Evidence-Based Review
Amoxicillin, a broad-spectrum aminopenicillin antibiotic, represents one of the most widely prescribed antibacterial agents in clinical practice. Derived from the basic penicillin nucleus, this beta-lactam antibiotic demonstrates enhanced activity against gram-negative organisms compared to its predecessors while maintaining efficacy against gram-positive bacteria. The molecular structure features an amino group that improves penetration through the outer membrane of gram-negative bacteria, significantly expanding its therapeutic utility beyond earlier penicillin derivatives. 1. Introduction: What is Amoxil?
augmentin
Augmentin is a widely prescribed antibiotic medication combining amoxicillin, a broad-spectrum penicillin, and clavulanate potassium, a beta-lactamase inhibitor. This combination therapy is specifically engineered to overcome bacterial resistance mechanisms, making it effective against a broader range of infections than amoxicillin alone. It’s available in various oral formulations including tablets, chewables, and suspensions, with different amoxicillin-to-clavulanate ratios to accommodate pediatric and adult dosing needs. The development of Augmentin represented a significant advancement in antimicrobial therapy when GlaxoSmithKline introduced it, addressing the growing problem of beta-lactamase mediated resistance that was rendering many penicillin derivatives ineffective.
benemid
Probenecid, a uricosuric agent first approved by the FDA in 1951, remains one of those fascinating drugs that keeps finding new relevance decades after its initial development. Originally developed to prolong penicillin activity by reducing its renal excretion, we quickly discovered its profound effects on uric acid handling. The chemical name is p-(dipropylsulfamoyl) benzoic acid, but in clinical practice we just call it probenecid or by its trade name Benemid. What’s remarkable is how this molecule continues to teach us about renal tubular transport systems even today.
Co-Amoxiclav: Effective Bacterial Infection Treatment - Evidence-Based Review
Co-amoxiclav represents one of those workhorse antibiotic combinations that every clinician ends up having a complicated relationship with over the years. It’s not the flashiest drug in our arsenal, but when you need broad-spectrum coverage with reliable beta-lactamase protection, it’s often the first thing that comes to mind. The combination of amoxicillin with clavulanic acid creates this interesting synergy - the amoxicillin handles the basic bacterial wall synthesis inhibition while clavulanic acid acts as this molecular bodyguard against the enzymes that would normally dismantle it.
Colchicine: Targeted Anti-Inflammatory Action for Gout and Beyond - Evidence-Based Review
Colchicine is a naturally occurring alkaloid derived primarily from the autumn crocus (Colchicum autumnale) and glory lily (Gloriosa superba). It’s one of the oldest medications still in clinical use today, with references dating back to ancient Egyptian times for treating joint swelling and pain. What’s fascinating is how this ancient remedy has found validated modern applications through rigorous clinical trials. In contemporary practice, colchicine serves as a potent anti-inflammatory agent with a unique mechanism distinct from NSAIDs or corticosteroids, making it particularly valuable for specific inflammatory conditions where other treatments fall short or pose greater risks.
cytoxan
Cytoxan, known generically as cyclophosphamide, is a potent alkylating chemotherapeutic and immunosuppressive agent with a long-standing role in oncology, rheumatology, and transplant medicine. It’s a prodrug activated in the liver, primarily used for its cytotoxic effects on rapidly dividing cells and its ability to modulate immune responses. This monograph provides a comprehensive, evidence-based review of Cytoxan, covering its composition, mechanisms, clinical applications, and practical considerations for use. Cytoxan: Potent Chemotherapy and Immunosuppression for Cancer and Autoimmune Diseases - Evidence-Based Review 1.
Imuran: Effective Immunosuppression for Autoimmune and Transplant Patients - Evidence-Based Review
Imuran, known generically as azathioprine, is an immunosuppressive medication that has been a cornerstone in managing autoimmune diseases and preventing organ transplant rejection for decades. It’s not a dietary supplement or medical device but a potent prescription drug metabolized to active thioguanine nucleotides that integrate into DNA, inhibiting purine synthesis and suppressing immune cell proliferation. This mechanism makes it invaluable for conditions where the immune system attacks the body’s own tissues.
theo 24 cr
Theo 24 CR represents a significant advancement in sustained-release theophylline therapy, specifically engineered to maintain stable serum concentrations over a 24-hour period. This extended-release formulation addresses the critical challenge of theophylline’s narrow therapeutic index while providing consistent bronchodilation for chronic respiratory conditions. The development team spent nearly three years perfecting the release matrix—we actually had to scrap two entire production batches when the dissolution profiles showed unacceptable peak-trough fluctuations. Dr. Chen from pharmacokinetics argued vehemently for a different polymer blend, while the clinical team insisted on maintaining the 24-hour coverage window.